Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe record history reflects a new version dated 2026-04-20 with an update to the study status, while a prior entry dated 2026-03-19 is removed.SummaryDifference0.2%

- Check14 days agoChange DetectedFooter shows a new site revision (v3.5.2), replacing the previous (v3.5.0). This update is limited to metadata and does not modify study data or visible content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedOn 2026-03-19, Contacts/Locations and Study Status were added to the record history, affecting 40 items. A deletion entry from 2026-02-20 is also recorded in the history.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.4.3 has been added to the history, and the previous v3.4.2 entry has been removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history now includes additions of Contacts/Locations and Study Status sections, expanding visibility of trial contact information and the current study status.SummaryDifference0.3%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.